Light Therapy for Alzheimer's Disease
Trial Summary
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Tailored Lighting Intervention for Alzheimer's Disease?
Research shows that using light therapy, like a self-luminous light table, can improve sleep and reduce agitation and depression in people with Alzheimer's. Tailored lighting interventions have been found to positively affect sleep quality, mood, and behavior in those with Alzheimer's and related dementias.12345
Is light therapy safe for people with Alzheimer's disease?
How is the Tailored Lighting Intervention treatment different from other treatments for Alzheimer's disease?
What is the purpose of this trial?
To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).
Research Team
Mariana Figueiro, PhD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Eligibility Criteria
This trial is for people with mild cognitive impairment or early Alzheimer's who have trouble sleeping and live at home. It's not suitable for those who are blind, need insulin for diabetes, have severe vision loss from macular degeneration, or serious sleep apnea.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a tailored light intervention (TLI) or placebo lighting intervention for 24 weeks to improve sleep, cognition, and metabolic control
Follow-up
Participants are monitored for long-term effects on sleep, cognition, and metabolic control
Treatment Details
Interventions
- Tailored Lighting Intervention
Tailored Lighting Intervention is already approved in United States, Canada for the following indications:
- Sleep disturbances in Alzheimer's disease and related dementia (ADRD)
- Improvement of cognition and metabolism in Mild Cognitive Impairment (MCI) or mild Alzheimer's disease
- Sleep disturbances in Alzheimer's disease and related dementia (ADRD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor